Zhengqiang Wang

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Topics

Hepatitis C Virus

Molecular Docking

Top Venues

Journal of medicinal chemistry

ACS infectious diseases

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Zhengqiang Wang
Novel diarylpyrimidine subtypes as HIV-1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile. Journal of medical virology 96 (3) (2024)
Thamina Akther, William M McFadden, Huanchun Zhang, Karen A Kirby, Stefan G Sarafianos, Zhengqiang Wang
Design and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein. International journal of molecular sciences 25 (7) (2024)
Thamina Akther, William M McFadden, Huanchun Zhang, Karen A Kirby, Stefan G Sarafianos, Zhengqiang Wang
Design and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein. International journal of molecular sciences 25 (7) (2024)
Thamina Akther, William M McFadden, Huanchun Zhang, Karen A Kirby, Stefan G Sarafianos, Zhengqiang Wang
Design and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein. International journal of molecular sciences 25 (7) (2024)
Zhengqiang Wang, Robert J Geraghty
Viral Nucleases. Viruses 15 (3) (2023)
Zhengqiang Wang, Robert J Geraghty
Viral Nucleases. Viruses 15 (3) (2023)
Ajit Dhananjay Jagtap, Robert J Geraghty, Zhengqiang Wang
Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds. Journal of medicinal chemistry (2023)
Zhengqiang Wang, Robert J Geraghty
Viral Nucleases. Viruses 15 (3) (2023)
Tianyu He, Tiffany C Edwards, Jiashu Xie, Hideki Aihara, Robert J Geraghty, Zhengqiang Wang
4,5-Dihydroxypyrimidine Methyl Carboxylates, Carboxylic Acids, and Carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease. Journal of medicinal chemistry 65 (7) (2022)
Eunkyung Jung, Ryuichi Majima, Tiffany C Edwards, Ruben Soto-Acosta, Robert J Geraghty, Zhengqiang Wang
8-Hydroxy-1,6-naphthyridine-7-carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease. ChemMedChem 17 (17) (2022)
Sameera Senaweera, Haijuan Du, Huanchun Zhang, Karen A Kirby, Philip R Tedbury, Jiashu Xie, Stefan G Sarafianos, Zhengqiang Wang
Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches. Viruses 13 (5) (2021)
Rajkumar Lalji Sahani, Thamina Akther, Maria E Cilento, Andres Emanuelli Castaner, Huanchun Zhang, Karen A Kirby, Jiashu Xie, Stefan G Sarafianos, Zhengqiang Wang
Potency and metabolic stability: a molecular hybrid case in the design of novel PF74-like small molecules targeting HIV-1 capsid protein. RSC medicinal chemistry 12 (12) (2021)
Rajkumar Lalji Sahani, Raquel Diana-Rivero, Sanjeev Kumar V Vernekar, Lei Wang, Haijuan Du, Huanchun Zhang, Andres Emanuelli Castaner, Mary C Casey, Karen A Kirby, Philip R Tedbury, Jiashu Xie, Stefan G Sarafianos, Zhengqiang Wang
Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74. Viruses 13 (3) (2021)
Qinfang Sun, Ronald M Levy, Karen A Kirby, Zhengqiang Wang, Stefan G Sarafianos, Nanjie Deng
Molecular Dynamics Free Energy Simulations Reveal the Mechanism for the Antiviral Resistance of the M66I HIV-1 Capsid Mutation. Viruses 13 (5) (2021)
Zhengqiang Wang
Challenges and Opportunities in Hepatitis B Research. ACS infectious diseases 5 (5) (2020)
Sanjeev Kumar V Vernekar, Rajkumar Lalji Sahani, Mary C Casey, Jayakanth Kankanala, Lei Wang, Karen A Kirby, Haijuan Du, Huanchun Zhang, Philip R Tedbury, Jiashu Xie, Stefan G Sarafianos, Zhengqiang Wang
Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules. Viruses 12 (4) (2020)
Zhaoyong Xi, Zhengqiang Wang, Stefan G Sarafianos, Nataliya S Myshakina, Rieko Ishima
Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H. ACS infectious diseases 5 (11) (2019)
Andrew D Huber, Dallas L Pineda, Dandan Liu, Kelsey N Boschert, Anna T Gres, Jennifer J Wolf, Emily M Coonrod, Jing Tang, Thomas G Laughlin, Qiongying Yang, Maritza N Puray-Chavez, Juan Ji, Kamalendra Singh, Karen A Kirby, Zhengqiang Wang, Stefan G Sarafianos
Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores. ACS infectious diseases 5 (5) (2019)
Lei Wang, Stefan G Sarafianos, Zhengqiang Wang
Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H. Accounts of chemical research 53 (1) (2019)
Jayakanth Kankanala, Carlos J A Ribeiro, Evgeny Kiselev, Azhar Ravji, Jessica Williams, Jiashu Xie, Hideki Aihara, Yves Pommier, Zhengqiang Wang
Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide. Journal of medicinal chemistry 62 (9) (2019)
Jayakanth Kankanala, Yan Wang, Robert J Geraghty, Zhengqiang Wang
Hydroxypyridonecarboxylic Acids as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease. ChemMedChem 13 (16) (2018)
Sanjeev Kumar V Vernekar, Jing Tang, Bulan Wu, Andrew D Huber, Mary C Casey, Nataliya Myshakina, Daniel J Wilson, Jayakanth Kankanala, Karen A Kirby, Michael A Parniak, Stefan G Sarafianos, Zhengqiang Wang
Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity. Journal of medicinal chemistry 60 (12) (2017)